REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,059,000 | +180.8% | 213,808 | +149.1% | 0.21% | +163.0% |
| Q3 2020 | $2,158,000 | +3.0% | 85,840 | 0.0% | 0.08% | +1.2% |
| Q2 2020 | $2,096,000 | +65.0% | 85,840 | 0.0% | 0.08% | +40.4% |
| Q1 2020 | $1,270,000 | -8.8% | 85,840 | 0.0% | 0.06% | +7.5% |
| Q4 2019 | $1,393,000 | -28.0% | 85,840 | +10.2% | 0.05% | -24.3% |
| Q3 2018 | $1,936,000 | -9.5% | 77,919 | 0.0% | 0.07% | -13.6% |
| Q2 2018 | $2,139,000 | +60.2% | 77,919 | +79.8% | 0.08% | +55.8% |
| Q1 2018 | $1,335,000 | +15.9% | 43,329 | +34.5% | 0.05% | +18.2% |
| Q4 2017 | $1,152,000 | -5.3% | 32,225 | -57.0% | 0.04% | -6.4% |
| Q3 2016 | $1,216,000 | +19.2% | 75,000 | 0.0% | 0.05% | +11.9% |
| Q2 2016 | $1,020,000 | +29.8% | 75,000 | +66.7% | 0.04% | +27.3% |
| Q1 2016 | $786,000 | – | 45,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |